President Trump meets the CEOs of tech titans such as Apple, Microsoft, Google, and Amazon.

John Fourier

2017-06-15 07:32:00 Thu ET

President Donald Trump has discussed with the CEOs of large multinational corporations such as Apple, Microsoft, Google, and Amazon. This discussion includes Apple CEO Tim Cook, Amazon CEO Jeff Bezos, Palantir CEO Alex Karp, and many more. Trump calls for a sweeping transformation of the U.S. government's IT infrastructure to catch up with the private sector.

Apple CEO Tim Cook suggests that the government can embed the essential programming tools and skills in standard school curriculum in order to promote better cybersecurity, encryption, and smart data analysis.

The corporate leaders affirm and welcome the Trump tax incentive plan to boost U.S. economic output, employment, and stock market performance. FAMGA can then repatriate their abundant offshore cash stockpiles to invest in strategic mergers and acquisitions of small tech startups with proprietary technologies to complement FAMGA's extant platforms, networks, and algorithms.

In recent years, we have seen several strategic tech-savvy acquisitions: Apple acquires Anobit and AuthenTec; Amazon acquires Zappos, Kiva Systems, and Whole Foods; Google acquires YouTube, Motorola, and DeepMind; Facebook acquires WhatsApp, Instagram, and Oculus; Microsoft acquires Genee, Skype, LinkedIn, Solair, and Datazen etc. This tech trend continues as FAMGA keeps its dominant position in the markets for mobile technologies, software solutions, and cloud services.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

Net neutrality rules continue to revolve around the Trump administration's current IT agenda of 5G telecom transformation.

Becky Berkman

2018-05-15 08:40:00 Tuesday ET

Net neutrality rules continue to revolve around the Trump administration's current IT agenda of 5G telecom transformation.

Net neutrality rules continue to revolve around the Trump administration's current IT agenda of 5G telecom transformation. Republican Senate passes the

+See More

Strategic managers envision lofty purposes to enjoy incremental consistent progress over time.

Jonah Whanau

2020-10-06 09:31:00 Tuesday ET

Strategic managers envision lofty purposes to enjoy incremental consistent progress over time.

Strategic managers envision lofty purposes to enjoy incremental consistent progress over time. Allison Rimm (2015)   The joy of strategy: a bu

+See More

President Trump praises great unity and progress at the G7 summit.

Rose Prince

2019-09-21 09:25:00 Saturday ET

President Trump praises great unity and progress at the G7 summit.

President Trump praises great unity and progress at the G7 summit with respect to Sino-U.S. trade conflict resolution, global climate change, containment fo

+See More

PwC releases a new study of top innovators worldwide as of November 2018.

Daphne Basel

2018-11-07 08:30:00 Wednesday ET

PwC releases a new study of top innovators worldwide as of November 2018.

PwC releases a new study of top innovators worldwide as of November 2018. This study assesses the top 1,000 global companies that spend the most on R&D

+See More

Corporate diversification theory and evidence

James Campbell

2022-04-05 17:39:00 Tuesday ET

Corporate diversification theory and evidence

Corporate diversification theory and evidence A recent strand of corporate diversification literature spans at least three generations. The first generat

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More